Intelligent Bio Solutions (INBS) Asset Writedowns and Impairment (2022 - 2024)
Intelligent Bio Solutions' quarterly Asset Writedowns and Impairment came in at $263.0 in Q1 2024, down 77.42% quarter-over-quarter from $1165.0 in Q4 2023.
Intelligent Bio Solutions has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $263.0 in Q1 2024.
- For the quarter ending Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $263.0; the trailing twelve-month figure through Mar 2024 stood at $72115.0 (changed N/A YoY), and the FY2025 full-year result was $220062.0, changed N/A from the prior year.
- Asset Writedowns and Impairment for Q1 2024 stood at $263.0, down from $1165.0 in the prior quarter.
- The five-year high for Asset Writedowns and Impairment was $67851.0 in Q3 2023, with the low at $263.0 in Q1 2024.
- Average Asset Writedowns and Impairment over 3 years is $19006.6, with a median of $2836.0 recorded in 2023.
- Peak annual rise in Asset Writedowns and Impairment reached 94.92% in 2023, while the deepest fall reached 94.92% in 2023.
- Tracing INBS's Asset Writedowns and Impairment over 3 years: stood at $22918.0 in 2022, then plunged by 94.92% to $1165.0 in 2023, then tumbled by 77.42% to $263.0 in 2024.
- The last three Asset Writedowns and Impairment figures came in at $263.0 (Q1 2024), $1165.0 (Q4 2023), and $67851.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Intelligent Bio Solutions | 13.61 Mn | 12.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 263.00 |
| Mar 31, 2024 | 263.00 |
| Dec 31, 2023 | 1,165.00 |
| Dec 31, 2023 | 1,165.00 |
| Sep 30, 2023 | 67,851.00 |
| Sep 30, 2023 | 67,851.00 |
| Jun 30, 2023 | 2,836.00 |
| Jun 30, 2023 | 2,836.00 |
| Dec 31, 2022 | 22,918.00 |
| Dec 31, 2022 | 22,918.00 |